RADCam Enterprise Combines Video with Intelligent Speaking Agentic AI for Systems Integrators and Enterprise Camera Systems Detroit, Michigan, Sept. 15, 2025 (GLOBE NEWSWIRE) — Artificial Intelligence Technology Solutions, Inc. (the “Company”) (OTCID:AITX), a global leader in AI-driven security and productivity solutions, along with its subsidiary, Robotic Assistance Devices, Inc. (RAD-I), today announced the commercial availability of RADCam™ Enterprise, a proactive video security platform now compatible with the industry’s leading Video Management Systems (VMS). The intelligent talking camera can be integrated quickly and seamlessly into virtually any professional-grade video system. The Company first introduced the RADCam Enterprise initiative on May 5, 2025, highlighting its expansion beyond residential applications...

GAITHERSBURG, Md., Sept. 15, 2025 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) today announced it has received a $17 million contract modification from the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS), to supply TEMBEXA® (brincidofovir) oral suspension. This follows the U.S. Food and Drug Administration’s (FDA) recent approval of the manufacturing scale-up of TEMBEXA® oral suspension. Oral suspension formulation is an important option for patients who may have trouble swallowing due to age or medical status. “Our newly secured contract modification and ongoing collaboration with BARDA and its procurement of TEMBEXA® (brincidofovir) oral suspension formulation reinforces...

New Agreement with One of the Largest Emergency Response Organizations in Asia Includes Advanced Decontamination, Care Services and Maintenance for Firefighter Protective Gear HUNTSVILLE, Ala., Sept. 15, 2025 (GLOBE NEWSWIRE) — Lakeland Industries, Inc. (“Lakeland Fire + Safety” or “Lakeland”) (NASDAQ: LAKE), a leading global manufacturer of protective clothing and apparel for industry, healthcare and first responders, today announced that its subsidiary, Lakeland LHD, has been awarded an approximately USD $5.6 million three-year contract to provide advanced decontamination, managed care and maintenance services for the Hong Kong Fire Services Department’s (HKFSD) firefighter protective gear, one of the largest emergency response organizations in Asia. With more than 11,000 uniformed and civilian personnel...

DAYTONA BEACH, Fla., Sept. 15, 2025 (GLOBE NEWSWIRE) — TopBuild Corp. (NYSE:BLD) (“TopBuild” or the “Company”), a leading installer of insulation and commercial roofing and a specialty distributor of insulation and related building material products to the construction industry in the United States and Canada, today announced a private offering of $750.0 million aggregate principal amount of senior notes due 2034 (the “notes”) to qualified institutional buyers in accordance with Rule 144A under the Securities Act of 1933 (the “Securities Act”) and to certain non-U.S. persons in offshore transactions in accordance with Regulation S under the Securities Act. TopBuild intends to use the net proceeds from the sale of the notes for general corporate purposes, which may include acquisitions. The notes will be guaranteed, on an unsecured...

The demonstrations were conducted using Trexmatic’s multi-purpose robotics platform while using ParaZero’s DefendAir as an Anti-Drone component, showcasing the ability to safeguard borders and sensitive facilities against hostile drones Kfar Saba, Israel, Sept. 15, 2025 (GLOBE NEWSWIRE) — ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry, announces the successful completion of a field trial of its DefendAir Stationary Turret system with The Israeli Ministry of Defense’s Department of Defense, the Chief Scientist Office, the Ministry of National Security, the Israeli the Prison Service, and Trexmatic. The trial demonstrated the DefendAir’s effectiveness in securing critical...

ATH434 demonstrated clinically meaningful efficacy in modifying disease progression and was well tolerated at both 50 and 75 mg doses MELBOURNE, Australia and SAN FRANCISCO, Sept. 15, 2025 (GLOBE NEWSWIRE) — Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that data from the ATH434-201 randomized, double-blind Phase 2 clinical trial in Multiple System Atrophy (MSA) was presented at the 150th Annual Meeting of the American Neurological Association (ANA), held in Baltimore, MD. A poster, entitled, “ATH434 Slowed Disease Progression in a Phase 2 Study in Multiple System Atrophy,” was presented by Daniel Claassen, M.D., M.S., Professor of Neurology at Vanderbilt University Medical...